Collectively, these studiesprovide an intriguing contrast in the consequences of misregulation of BRG1.Additional studies will be needed to better define the oncogenic versustumor suppressive properties of BRG1 in CRC. The gene discussed is SMARCA4; the disease is colorectal carcinoma.